BioNTech, a German-based biotechnology company with a focus on developing cancer therapies, previously predicted that messenger-RNA technology could be used to rapidly develop a vaccine in the event of a pandemic.

The company, founded by Dr Ugur Sahin and Dr Ozlem Tureci, in partnership with Pfizer, announced this week that their COVID-19 vaccine candidate is more than 90% effective.

To read more, please follow the link below:

The New York Times: The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19